Tamiflu, Bad Pharma, and the UK Public Accounts Committee

The conclusion that millions of people have been exposed to a treatment, at enormous cost to the public purse, despite the fact that independent researchers have been unable to verify it as being effective or safe, should trouble us all.

Dr David Tovey writes about the lack of transparency in clinical trials, with specific reference to Tamiflu, and the ongoing public campaign after the publication of Ben Goldacre’s book Bad Pharma.

TRiG.

Leave a Reply

Your email address will not be published. Required fields are marked *